Clinical trial
Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable…
NCT00193726 · Sudeep Gupta, Other · Terminated
Key facts
| NCT number | NCT00193726 |
|---|---|
| Title | Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer |
| Official title | Estrogen Priming to Increase the Efficacy of Standard Adjuvant Chemotherapy in Operable Breast Cancer. |
| Lead sponsor | Sudeep Gupta, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Tab Premarin (Ethinyl estradiol), Placebo |
| Enrollment | 273 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 30, 2012 |
| Completion | Mar 30, 2012 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 20, 2018 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: